Articles
Replicel has shared a newsletter today, March 5, 2019, addressing several facets of the company’s progress and product development. The big question for many people lately has been an update on RCH-01/Shiseido, this topic is briefly addressed in the newsletter. Replicel states that “With the clinical study of RCH-01 now successfully completed in Japan, RepliCel…
Read MoreI’ve been given a few samples of the male Trinov version and I thought it would be fun to do a little giveaway. Let’s start with one bottle. The winner selection will be random but please share a few words on how Follicle Thought has helped your life or something else you feel would make…
Read MoreHairClone of the UK will be winding up its crowdfunding campaign soon. Paul Kemp, CEO of HairClone, has released the 6th official HairClone newsletter today. The main theme of the newsletter is to allow people a last chance opportunity to own shares in HairClone via its crowdfunding campaign on CapitalCell. The rest of the newsletter…
Read MoreOn February 4, 2019 Follicum announced via press release they have completed a preclinical trial using a new cream-like topical formulation of their peptide FOL-005. In the trial, Follicum measured the effects of their topical FOL-005 against industry standard hair-growth drug minoxidil. The trial was done on mice and took about four weeks to complete.…
Read MorePlease enjoy the second part of our interview series with Paul Kemp PhD, CEO of HairClone. FT: Can you give us a step-by-step of how a therapy like HairClone’s goes from the R&D phase into the clinical setting? PK: If you consider it at its very simplest there are 4 players involved in any treatment. The…
Read MoreRiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…
Read MoreUpdated It’s been over a month since the long anticipated Trinov product was released in Italy. Across the internet you can find people sharing stories of their Trinov orders arriving. Now that the product is widely available and several readers of Follicle Thought have shared that they are now using the product, it’s time to…
Read MoreHappy Holidays to all of the readers of Follicle Thought. I’m pleased to be bringing you all an exclusive interview with the UK-based startup HairClone, I hope you enjoy it with your celebrations this year. As many of you know, HairClone has recently launched a crowdfunding campaign in order to advance its R&D and setup…
Read MoreA clinical trial has begun for HairCell, a startup in the Leonhardt Ventures portfolio which seeks to rejuvenate hair using bioelectric stimulation and biologics. Leonhardt Ventures is a regenerative medtech company which is developing around 30 startup companies for various types of organ regeneration and recovery. The core technology of all of these companies is…
Read MoreIn November, the UK based magazine “Cosmetic Business” released a Trend Report on the latest happenings in the hair growth industry. The November Trend Report features commentary from several hair transplant surgeons and also from yours truly, FollicleThought.com. On The Horizon Within the article, hair transplant surgeon Dr. Robert Jones endorses HairClone on being at…
Read More